The deal values Advent at $358 million. Advent manufactures fuel cells for electric vehicles. Read more.
AMCI Files Proxy for Advent Technologies Merger
Related Posts
BioPlus Acquisition Files Investor Presentation on $195M Avertix Medical Deal
Avertix is a medical implant company focused on improving long-term management and outcomes of high-risk coronary disease in patients who have survived one or more heart attacks.
Silver Sustainable Solutions Withdraws $250M IPO
Backed by Guggenheim Partners, the SPAC was planning to focus on companies that develop, use or sell clean economy technologies.
Blue Ocean Files Investor Presentation on $275M TNL Mediagene Deal
The target is an Asian digital-media company. If the merger is approved, the combined company intends to build TNL Mediagene’s presence in Japan, Taiwan and Southeast Asia, delivering politically neutral content on news, business, technology, science, sports, food and lifestyles.
Spring Valley Completes $230M IPO
Spring Valley's sponsor is an affiliate of Pearl, an investment firm that invests in the North American energy industry.